Deoxycholic acid - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for deoxycholic acid and what is the scope of freedom to operate?
Deoxycholic acid
is the generic ingredient in two branded drugs marketed by Wilshire Pharms Inc and Abbvie, and is included in two NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Deoxycholic acid has one hundred and forty-one patent family members in thirty-seven countries.
There are thirty-three drug master file entries for deoxycholic acid. One supplier is listed for this compound.
Summary for deoxycholic acid
International Patents: | 141 |
US Patents: | 15 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 33 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 20 |
Patent Applications: | 6,163 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for deoxycholic acid |
What excipients (inactive ingredients) are in deoxycholic acid? | deoxycholic acid excipients list |
DailyMed Link: | deoxycholic acid at DailyMed |
Recent Clinical Trials for deoxycholic acid
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Phase 1 |
Massachusetts General Hospital | Phase 1 |
Juva Skin & Laser Center | Phase 4 |
Pharmacology for deoxycholic acid
Drug Class | Cytolytic Agent |
Physiological Effect | Decreased Cell Membrane Integrity |
Medical Subject Heading (MeSH) Categories for deoxycholic acid
Anatomical Therapeutic Chemical (ATC) Classes for deoxycholic acid
Paragraph IV (Patent) Challenges for DEOXYCHOLIC ACID
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
KYBELLA | Injection | deoxycholic acid | 10 mg/mL (2 mL) | 206333 | 1 | 2018-07-13 |
US Patents and Regulatory Information for deoxycholic acid
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,101,593 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,242,294 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,653,058 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 9,522,155 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
Wilshire Pharms Inc | DEOXYCHOLIC ACID | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 212296-001 | Apr 2, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 10,500,214 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for deoxycholic acid
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 5279274 | ⤷ Subscribe | |
Japan | 2012176966 | METHOD AND RELATED COMPOSITION FOR REDUCTION OF FAT | ⤷ Subscribe |
Taiwan | 201534684 | Synthetic bile acid composition, method, and preparation | ⤷ Subscribe |
South Korea | 101916024 | ⤷ Subscribe | |
Cyprus | 1112204 | ⤷ Subscribe | |
Israel | 207126 | תכשירים להפחתה בשומן (Compositions for reduction of fat) | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for deoxycholic acid
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1758590 | CR 2017 00067 | Denmark | ⤷ Subscribe | PRODUCT NAME: DEOXYCHOLSYRE NATRIUMSALT; NAT. REG. NO/DATE: 59040 (DK) 20170703; FIRST REG. NO/DATE: IS IS/1/16/071/01 20160729 |
3692995 | 301229 | Netherlands | ⤷ Subscribe | PRODUCT NAME: DEOXYCHOLAAT; NATIONAL REGISTRATION NO/DATE: RVG120593 20170804; FIRST REGISTRATION: IS IS/1/16/071/01 20160729 |
2380576 | 122020000056 | Germany | ⤷ Subscribe | PRODUCT NAME: DEOXYCHOLSAEURE NATRIUMSALZ; NAT. REGISTRATION NO/DATE: 98586.00.00 20180104; FIRST REGISTRATION: EWR IS/1/16/071/01 20160729 |
1758590 | PA2017006 | Lithuania | ⤷ Subscribe | PRODUCT NAME: DEZOKSICHOLIO RUGSTIES NATRIO DRUSKA; REGISTRATION NO/DATE: LT/1/16/3960/001 20160909 |
2380576 | SPC/GB20/050 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; REGISTERED: UK PL 45496/0009 20170526 |
2380576 | 20C1048 | France | ⤷ Subscribe | PRODUCT NAME: SEL DE SODIUM DE L'ACIDE DESOXYCHOLIQUE; NAT. REGISTRATION NO/DATE: NL46299 20180810; FIRST REGISTRATION: IS - IS/1/16/071/01 20160729 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.